Emmaus Life Sciences (EMMA) Stock Chart & Stock Price History → Overlooked Mineral Essential To Quantum Computing and AI (From Capital Trends) (Ad) Free EMMA Stock Alerts $0.09 0.00 (0.00%) (As of 06/4/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Emmaus Life Sciences Stock Price Performance5 Day Performance0.00%1 Month Performance-8.00%3 Month Performance-8.91%6 Month Performance-26.40%Year-To-Date Performance-8.07%1 Year Performance-71.25% Receive EMMA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsPlease, take this warning seriously todayWall Street Legend Warns "Mass Bank Run" is Coming Man who predicted 2023 bank run warns it could soon get worse. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. EMMA Stock Chart for Wednesday, June, 5, 2024 EMMA Chart by TradingView Emmaus Life Sciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/04/2024$0.09$0.09$0.09$0.0920,000 shs$5.88 million06/03/2024$0.09$0.09-0.04%$0.09$0.09800 shs$5.88 million05/31/2024$0.09$0.09-0.11%$0.09$0.09850 shs$5.88 million05/30/2024$0.09$0.09-2.91%$0.09$0.0910,000 shs$5.88 million05/29/2024$0.09$0.09-0.04%$0.09$0.09204 shs$6.06 million05/28/2024$0.09$0.09+3.04%$0.09$0.09204 shs$6.06 million Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 05/27/2024$0.09$0.09$0.09$0.09100 shs$5.88 million05/24/2024$0.10$0.09-4.16%$0.09$0.09105 shs$5.88 million05/23/2024$0.09$0.10+1.30%$0.10$0.10792 shs$6.14 million05/22/2024$0.10$0.09-5.14%$0.09$0.0910,010 shs$6.06 million05/21/2024$0.10$0.10$0.10$0.1012,899 shs$6.39 million05/20/2024$0.10$0.10$0.10$0.1010,000 shs$6.39 million05/17/2024$0.10$0.10-2.91%$0.10$0.103,610 shs$6.39 million05/16/2024$0.10$0.10$0.10$0.1010 shs$6.58 million05/15/2024$0.11$0.10-1.90%$0.10$0.10110 shs$6.58 million05/14/2024$0.11$0.11$0.11$0.11214 shs$6.71 million05/09/2024$0.10$0.11+5.00%$0.11$0.11214 shs$6.71 million05/08/2024$0.11$0.10-9.09%$0.10$0.108,504 shs$6.39 million05/07/2024$0.11$0.11$0.11$0.112,000 shs$7.03 million05/06/2024$0.10$0.11+10.00%$0.11$0.112,000 shs$7.03 million05/03/2024$0.10$0.10$0.10$0.102,288 shs$6.19 million05/02/2024$0.10$0.10$0.10$0.102,654 shs$6.19 million04/26/2024$0.10$0.10$0.10$0.10654 shs$6.19 million04/25/2024$0.10$0.10$0.10$0.104,635 shs$6.19 million04/24/2024$0.09$0.10+8.57%$0.10$0.104,635 shs$6.19 million04/23/2024$0.09$0.09+0.01%$0.09$0.0933 shs$5.70 million04/22/2024$0.09$0.09-0.01%$0.10$0.0966,100 shs$5.70 million04/19/2024$0.11$0.09-19.03%$0.10$0.0966,100 shs$5.70 million04/18/2024$0.11$0.11$0.11$0.1141 shs$7.04 million04/17/2024$0.11$0.11-0.04%$0.11$0.1141 shs$7.04 million04/16/2024$0.11$0.11+8.38%$0.11$0.11300 shs$7.04 million04/10/2024$0.11$0.11-5.62%$0.11$0.113,520 shs$6.49 million04/09/2024$0.11$0.11+5.95%$0.11$0.11833 shs$6.88 million04/08/2024$0.11$0.11-5.41%$0.11$0.113,520 shs$6.49 million04/05/2024$0.11$0.11+6.00%$0.12$0.11833 shs$6.88 million04/04/2024$0.11$0.11-7.69%$0.11$0.11100 shs$6.49 million04/03/2024$0.11$0.11$0.11$0.11166 shs$7.04 million04/02/2024$0.11$0.11$0.11$0.11166 shs$7.04 million04/01/2024$0.11$0.11+8.33%$0.11$0.11166 shs$7.04 million03/29/2024$0.12$0.11-10.26%$0.13$0.115,333 shs$6.49 millionBiden v. Who in 2024???? (Ad)I predict that the real battle for the 2024 election is NOT between Joe Biden and Donald Trump. It will be between Joe Biden and ____ _____. (It's NOT RFK Jr.)Click here to see who03/28/2024$0.12$0.12$0.13$0.112,595 shs$7.24 million03/27/2024$0.09$0.12+30.00%$0.12$0.12215 shs$7.24 million03/25/2024$0.10$0.10$0.10$0.1026,901 shs$6.37 million03/22/2024$0.13$0.10-19.53%$0.12$0.1026,901 shs$6.37 million03/21/2024$0.09$0.13+42.22%$0.13$0.1010,410 shs$7.92 million03/20/2024$0.09$0.09+5.02%$0.09$0.091,151 shs$5.57 million03/19/2024$0.10$0.09-15.23%$0.09$0.09938 shs$5.30 million03/18/2024$0.10$0.10$0.10$0.105,000 shs$6.25 million03/15/2024$0.12$0.10-12.09%$0.11$0.1012,000 shs$6.25 million03/14/2024$0.12$0.12$0.13$0.1220,016 shs$7.11 million03/13/2024$0.11$0.12+3.05%$0.13$0.1220,016 shs$7.11 million03/12/2024$0.11$0.11+1.32%$0.11$0.10835 shs$6.90 million03/11/2024$0.11$0.11+1.33%$0.11$0.11110 shs$6.81 million03/08/2024$0.11$0.11-2.60%$0.11$0.111,863 shs$6.72 million03/07/2024$0.11$0.11-2.62%$0.11$0.11100 shs$6.90 million03/06/2024$0.10$0.11+13.47%$0.13$0.1012,939 shs$7.09 million03/05/2024$0.11$0.10-8.18%$0.13$0.1013,766 shs$6.25 million03/04/2024$0.13$0.11-13.39%$0.13$0.0931,000 shs$6.80 million Related Companies: Apollomics Stock Chart Biora Therapeutics Stock Chart Viracta Therapeutics Stock Chart Bullfrog AI Stock Chart BriaCell Therapeutics Stock Chart CytoMed Therapeutics Stock Chart Sol-Gel Technologies Stock Chart Forte Biosciences Stock Chart iBio Stock Chart Bioxytran Stock Chart Receive EMMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:EMMA) was last updated on 6/5/2024 by MarketBeat.com Staff From Our PartnersThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…Porter & Company| SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes| SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold| SponsoredPlease, take this warning seriously todayWall Street Legend Warns "Mass Bank Run" is Coming Man who predicted 2023 bank run warns it could soon get ...Chaikin Analytics| SponsoredBiden v. Who in 2024????I predict that the real battle for the 2024 election is NOT between Joe Biden and Donald Trump. It will be ...InvestorPlace| SponsoredTrump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absoluteDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold| SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises| SponsoredEverything from semiconductors to space shuttles depend on this overlooked mineralBoron is also at the heart of a breakthrough that could fuel one of mankind's most sensational advances in sem...Capital Trends| Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.